9.75 USD
+0.16
1.67%
At close Updated Apr 17, 4:00 PM EDT
Pre-market
After hours
9.66
-0.09
0.92%
1 day
1.67%
5 days
-0.51%
1 month
-8.02%
3 months
-3.75%
6 months
2.85%
Year to date
-2.5%
1 year
-4.6%
5 years
30%
10 years
30%
 

About: Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Employees: 24,524

0
Funds holding %
of 8,118 funds
Analysts bullish %
0
Positive news %
Price charts implemented using Lightweight Charts™